ConocoPhillips China and Children’s HeartLink Announce Cooperation to Increase Access to Treatment for Children with Congenital Heart Disease

COPC will provide CHL with funding in support of the program, which will focus on providing a series of international advanced training opportunities by which the hospital can enhance the expertise of its medical professionals in the pediatric CHD field. With COPC’s financial support, overseas medical professionals will be invited to Qingdao to provide on-site guidance for clinical scientific research, with the purpose of improving the treatment of CHD in children, and providing opportunities for QWCH’s medical professionals to study abroad, conduct remote consultations and participate in international academic programs.

With an average of six-to-eight out of 1,000 babies being born with CHD, the disease has unequivocally become a serious threat to the lives of newborns in China. Improving diagnostic accuracy and proper treatment to adequately care for newborns is still a major challenge for Chinese hospitals. Xing Quansheng, QWCH’s president said, “During this critical juncture and challenging time for QWCH Children's Heart Center to develop into world-class treatment institution, we have received COPC’s and CHL’s dedicated support and assistance. The cooperation will provide communication and training opportunities to us with advanced international medical teams, which can further improve the quality of our medical care services and the capacity of our team to truly make a difference. I believe that, thanks to the efforts of COPC and CHL, the program will achieve remarkable results.”

Regarding the collaboration, Mark Wheeler, COPC president, said, “ConocoPhillips has been in China for over 35 years and has developed multidimensional cooperation with leading Chinese partners. As a caring corporate citizen, we often provide support to help communities tackle some of the tough issues they face today and in the future.

CHD is a disease frequently encountered amongst newborn babies, putting severe emotional and financial burdens on the children’s families. COPC has a 10-year history of helping children across China who suffer from CHD, having helped more than 450 sick children receive treatment to date.

“Through our alliance with CHL, over the past four years the program has been implemented at both West China Hospital, to support the Southwest China region, and at Tianjin TEDA International Cardiovascular Hospital, to support the North China region. This year, the program will be expanded to Qingdao, benefiting East China in a sustainable way by enhancing the hospital’s capacity to ensure more children with illnesses receive quality treatment and can embrace a brighter future.” said Wheeler.

In China, the program has funded 150 medical professionals’ medical training and ensuring treatment for as many as 2,200 sick children over the past four years. “We are excited about this new partnership with QWCH and grateful to COPC for their financial support,” said CHL’s President Jackie Boucher. “This regional strategy to train more pediatric cardiac specialists in East China represents a continuation of COPC’s support of our work in Southwest and North China. It also aligns with our strategy to increase access to care throughout China.”

In addition to providing support to China’s healthcare challenges, COPC is taking on the tough issues facing China today—from the conservation of nature in diversified areas to education advocacy for underserved communities; and from healthcare improvement to disaster rehabilitation. Since 2001, COPC has donated and invested millions of dollars in CSR in China, benefiting thousands of people and families throughout the country.  

Mark WheelerMark Wheeler made speech at the launch ceremony

Group Photo at end of the launch ceremonyGroup Photo at end of the launch ceremony

--- # # # ---

About ConocoPhillips

ConocoPhillips is the world’s largest independent E&P company based on production and proved reserves. Headquartered in Houston, Texas, ConocoPhillips had operations and activities in 17 countries, $75 billion of total assets, and approximately 11,600 employees as of Sept. 30, 2017. Production excluding Libya averaged 1,403 MBOED for the nine months ended Sept. 30, 2017, and proved reserves were 6.4 billion BOE as of Dec. 31, 2016. For more information, go to   

About Children’s HeartLink

Since 1969 CHL has been dedicated to caring for children with heart disease. CHL invests in long-term, multi-phase partnerships to ensure greater access to pediatric cardiac care and currently works in Brazil, China, India, Malaysia and Vietnam. Thanks to an expanding team of medical volunteers, over 5,000 local doctors, nurses and technicians are now more equipped to care for children with heart disease. On an annual basis, over 96,000 children receive care at CHL’s partner hospitals and programs around the world. CHL’s goal is to develop 50 CHL Centers of Excellence by 2030.
For more information, please visit

About Qingdao Women and Children Hospital

QWCH is an advanced specialist medical center, which provides full range of women and children’s medical, health, and rehabilitation services. The medical center is the leader institution of the Hospital Network consisting of more than 20 members, covering a population of about 30 million in and around Great Qingdao Area. Heart Center of QWCH (Qingdao Children’s Heart Center, QCHC) from May 2004, is one of the largest specialized children’s heart center of China. QWCH is on the way to be a nationally renowned women and children’s medical center with its continuous efforts. For more information, please visit


Lluvia Wu 
Director, PR & Communications, ConocoPhillips China

Faith Adams
Children’s HeartLink

Xiuqin Chi
Communication Department, Qingdao Women and Children Hospital
+86 18505321126


This news release contains forward-looking statements. Forward-looking statements relate to future events and anticipated results of operations, business strategies, and other aspects of our operations or operating results. In many cases you can identify forward-looking statements by terminology such as "anticipate," "estimate," "believe," "continue," "could," "intend," "may," "plan," "potential," "predict," "should," "will," "expect," "objective," "projection," "forecast," "goal," "guidance," "outlook," "effort," "target" and other similar words. However, the absence of these words does not mean that the statements are not forward-looking. Where, in any forward-looking statement, the company expresses an expectation or belief as to future results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. However, there can be no assurance that such expectation or belief will result or be achieved. The actual results of operations can and will be affected by a variety of risks and other matters including, but not limited to, changes in commodity prices; changes in expected levels of oil and gas reserves or production; operating hazards, drilling risks, unsuccessful exploratory activities; difficulties in developing new products and manufacturing processes; unexpected cost increases; international monetary conditions; potential liability for remedial actions under existing or future environmental regulations; potential liability resulting from pending or future litigation; limited access to capital or significantly higher cost of capital related to illiquidity or uncertainty in the domestic or international financial markets; and general domestic and international economic and political conditions; as well as changes in tax, environmental and other laws applicable to our business. Other factors that could cause actual results to differ materially from those described in the forward-looking statements include other economic, business, competitive and/or regulatory factors affecting our business generally as set forth in our filings with the Securities and Exchange Commission. Unless legally required, ConocoPhillips undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.